SFY 2023 - 2024 Behavioral Health Expenditure Target (BHET) Report Summary - HIV-SNP
| SFY 2023 - 2024 MC BHET Report Summary | ||||||
|---|---|---|---|---|---|---|
| HIV SNP line of business | ||||||
| Plan | BHET % | BHET Target Expense | BHET Experience | Remittance | MMs | |
| Amida Care Inc. | 119.76% | $13,250,849 | $15,869,624 | $0 | 71,803 | |
| MetroPlus Health Plan, Inc | 150.24% | $8,049,823 | $12,094,348 | $0 | 43,907 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 80.94% | $6,551,554 | $5,302,596 | $986,895 | 32,436 | |
| Total | $27,852,226 | $33,266,569 | $986,895 | 148,146 | ||
NOTES:
BHET Target 96%
